Ma, Linyuan
Ruan, Jinxue
Song, Jun http://orcid.org/0000-0002-6128-6378
Wen, Luan
Yang, Dongshan
Zhao, Jiangyang http://orcid.org/0000-0001-5484-3845
Xia, Xiaofeng
Chen, Y. Eugene http://orcid.org/0000-0003-2357-7825
Zhang, Jifeng http://orcid.org/0000-0001-5161-4705
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (HL068878, HL129778, HL138139)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (GM122181)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
U.S. Department of Health & Human Services | NIH | NIH Office of the Director (OD023194)
Article History
Received: 8 May 2020
Accepted: 29 October 2020
First Online: 27 November 2020
Competing interests
: J.X., Y.E.C., and X.X. are equity holders of ATGC Inc., a licensee of the miCas9 technology from the University of Michigan. The remaining authors declare no competing interests.